Molecular Diagnostics

Minimally Invasive Device Combined With Molecular Biomarkers Detects Early Esophageal Cancer
A novel, minimally invasive biomarker-based strategy has demonstrated a 90% success rate in detecting esophageal squamous cell carcinoma (ESCC) which comprises 80% of esophageal cancers globally. More...19 May 2022

Rapid Result Test for Complicated Urinary Tract Infections Proves Superior to Standard Urine Culture
Complicated urinary tract infections (cUTIs) are a significant burden on individual health and healthcare resources that must be diagnosed and treated early and accurately to reduce the risk of poor outcomes. Now, an advanced rapid result test better addresses polymicrobial infections in difficult cases, where bacterial interactions can impact antibiotic resistance. More...18 May 2022

First Fully Automated, Standardized Pre-Analytical Platform for Comprehensive Liquid Biopsy Testing
The first ever universal blood sample preparator for liquid biopsy analysis performs a completely automated and standardized preparation of a blood sample at the point of blood collection. More...18 May 2022


Qiagen Launches Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
QIAGEN N.V. (Venlo, Netherlands) has launched QIAstat-Dx Rise - a high-capacity version of the QIAstat-Dx automated syndromic system - and introduced enhancements to the menu of tests for the fully integrated one-step molecular testing solution that provides results in about one hour. More...17 May 2022

Quidel Triage Cardiac Panel Facilitates Rapid POC Diagnosis of Chest Pain Patients in ED
A point-of-care (POC), serial multi-marker testing strategy has been shown to facilitate the rapid diagnosis and management of chest pain patients in the emergency department (ED). Quidel Corporation (San Diego, CA, USA) has developed the Triage Cardiac Panel for use in the ED that is FDA cleared to aid in the diagnosis of myocardial infarction. More...17 May 2022

Meningioma DNA Methylation Groups Identify Biological Drivers and Therapeutic Vulnerabilities
Meningioma, also known as meningeal tumor, is typically a slow-growing tumor that forms from the meninges, the membranous layers surrounding the brain and spinal cord. Symptoms depend on the location and occur as a result of the tumor pressing on nearby tissue. More...16 May 2022
In Other News
Rapid POC Test for Diagnosis of Preeclampsia Could Prevent Unnecessary Hospitalization
BioMérieux’s New Automated Tests for Chikungunya Virus Diagnosis Offer Better Traceability
Lab-on-a-Chip Technology Detects Hard-to-Diagnose Diseases
Syphilis Antibody Assay Combines Screening and Confirmation in One POC Test
First-of-Its-Kind Multiplex Protein-Based Urine Test Detects Bladder Cancer
Rapid Ovarian Cancer Test Cuts Surgical Procedure Time and Infection Risk
Quantitative Test for Post-Transplant Pathogen Detection Improves Patient Outcomes
Simple Blood Sample to Diagnose TBI Severity Could Reduce Need for MRI Scan
RNA-Based Liquid Biopsy Strategy Enables Early Detection of Multiple Cancers
New Method Identifies Viruses in Tumors in Routine Clinical Genomic Sequencing Assay
Simple Blood Test Could Diagnose Ovarian Cancer Faster and Reduce Biopsies
Biohit's GastroPanel Blood Test Accurately Diagnoses Hp Infection and AG Before Endoscopy
A Simple Blood Test Detects Suicidal Tendencies in Individuals with Major Depressive Disorder
Portable RT-PCR Molecular Test Detects Dengue Virus with High Accuracy
Fujirebio’s Spinal-Tap Test for Alzheimer’s Disease Could Eliminate Need for PET Scans
Metabolomic Profile Predicts Type II Diabetes Risk for Normal Weight Individuals
First-Ever Test Indicates Risk of Preeclampsia Months Before Symptoms Occur
Automated Nasal Swab Technology Creates Hands-Free Diagnostics Workflow
Newly Launched Blood Test Detects Early Signs of Colorectal Cancer
Genetic Changes Identified in Patients Who Progress to Esophageal Cancer
Troponin Blood Test Offers Quick Method for Monitoring Patients after Cardiac Surgery
Lipid Profiling of Blood Samples Reveals Biomarkers for Cardiometabolic Disease Risk
Blood Biomarker Test Can Predict Dementia Before Symptoms Develop
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.